NASDAQ:RETA
Reata Pharmaceuticals
- Stock
Last Close
172.32
25/09 20:00
Market Cap
6.57B
Beta: 1.53
Volume Today
1.91M
Avg: 1.45M
PE Ratio
−81.11
PFCF: −26.32
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -11.11M - | -11.11M 0% | ||||||||
average payables | 1.59M - | 2.15M 34.84% | 3.68M 71.35% | 2.95M 19.89% | 3.27M 10.90% | 3.19M 2.43% | 3.35M 4.97% | 9.15M 173.14% | 16.11M 76.06% | |
average receivables | 13.07M - | 23.58M 80.39% | 15.96M 32.32% | 11.11M - | 11.11M 0% | |||||
book value per share | -49.86 - | -49.66 0.40% | -14.60 70.60% | -6.14 57.94% | -15.17 147.08% | -23.36 53.96% | -28.43 21.69% | -34.57 21.61% | -1.81 94.77% | |
capex per share | -0.03 - | -0.05 48.63% | -0.02 65.31% | -0.01 16.23% | -0.02 70.53% | -0.09 258.56% | -0.03 68.71% | -0.04 33.06% | -0.09 146.05% | |
capex to depreciation | -0.07 - | -0.15 105.26% | -0.50 233.39% | -0.79 57.90% | -1.58 100.13% | -2.87 82.05% | -0.82 71.55% | -1.10 35.38% | -2.89 161.94% | |
capex to operating cash flow | 0.00 - | 0.01 195.24% | 0.02 189.60% | 0.00 76.60% | 0.01 96.14% | 0.01 31.33% | 0.00 72.98% | 0.01 96.06% | 0.02 183.91% | |
capex to revenue | -0.00 - | -0.01 53.46% | -0.01 26.16% | -0.01 4.96% | -0.01 77.01% | -0.10 695.57% | -0.10 1.96% | -0.12 12.53% | -1.48 1,175.77% | |
cash per share | 15.96 - | 7.64 52.13% | 4.28 44.02% | 5.42 26.82% | 12.19 124.87% | 21.84 79.13% | 24.27 11.12% | 16.25 33.04% | 10.67 34.35% | |
days of inventory on hand | ||||||||||
days payables outstanding | 5.60 - | |||||||||
days sales outstanding | 107.09 - | 231.58 116.25% | 899.57 - | |||||||
debt to assets | 0.04 - | 0.04 16.50% | 0.07 54.46% | 0.14 109.92% | 0.27 89.16% | 0.48 75.75% | 0.10 78.83% | 0.19 85.67% | 0.23 22.63% | |
debt to equity | -0.02 - | -0.01 26.48% | -0.02 64.54% | -0.13 527.79% | -0.23 68.71% | -0.46 105.54% | -0.09 80.28% | -0.11 21.44% | -1.82 1,540.61% | |
dividend yield | ||||||||||
earnings yield | 0.01 - | -0.02 310.45% | -0.01 28.64% | -0.07 388.61% | -0.05 26.31% | -0.05 9.96% | -0.06 27.39% | -0.31 422.24% | -0.23 27.20% | |
enterprise value | -15.87M - | 29.88M 288.23% | 347.87M 1,064.32% | 567.63M 63.17% | 1.30B 128.23% | 5.71B 340.62% | 3.35B 41.33% | 503.57M 84.96% | 1.46B 189.33% | |
enterprise value over ebitda | -2.60 - | 20.56 889.43% | -54.24 363.76% | -12.21 77.48% | -16.95 38.76% | -20.08 18.49% | -14.87 25.93% | -2.07 86.09% | -5.42 161.89% | |
ev to operating cash flow | 0.18 - | -0.67 473.88% | -18.06 2,597.55% | -6.82 62.25% | -15.46 126.80% | -22.73 46.99% | -10.39 54.29% | -2.14 79.44% | -7.13 233.86% | |
ev to sales | -0.31 - | 0.59 294.34% | 6.98 1,075.14% | 11.81 69.28% | 24.17 104.68% | 215.27 790.47% | 371.33 72.50% | 43.83 88.20% | 657.49 1,400.21% | |
free cash flow per share | -16.15 - | -8.16 49.45% | -0.99 87.88% | -3.49 253.18% | -3.05 12.71% | -8.35 173.72% | -9.59 14.91% | -6.53 31.95% | -5.71 12.44% | |
free cash flow yield | -1.24 - | -0.62 49.45% | -0.05 92.75% | -0.12 172.25% | -0.05 55.94% | -0.04 24.89% | -0.08 90.02% | -0.25 219.01% | -0.15 39.22% | |
graham net net | -54.67 - | -52.03 4.82% | -11.07 78.72% | -6.37 42.44% | 0.28 104.38% | 7.85 2,709.30% | 11.38 44.93% | 1.14 90.02% | -5.30 567.30% | |
graham number | 11.86 - | 17.16 44.78% | 10.16 40.80% | 16.59 63.27% | 31.51 89.92% | 70.81 124.76% | 68.56 3.18% | 79.80 16.40% | 18.69 76.57% | |
income quality | -128.64 - | 30.77 123.92% | 3.09 89.95% | 1.75 43.53% | 1.04 40.44% | 0.87 16.79% | 1.30 50.32% | 0.79 39.08% | 0.65 17.37% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -32.26 - | -12.45 61.42% | -25.47 104.64% | -6.15 75.84% | -4.60 25.32% | -6.47 40.74% | ||||
interest debt per share | 0.88 - | 0.64 26.77% | 0.31 51.62% | 0.88 183.60% | 3.64 313.41% | 11.18 207.18% | 3.69 67.03% | 5.30 43.75% | 4.44 16.21% | |
inventory turnover | ||||||||||
invested capital | -0.02 - | -0.01 26.48% | -0.02 64.54% | -0.13 527.79% | -0.23 68.71% | -0.46 105.54% | -0.09 80.28% | -0.11 21.44% | -1.82 1,540.61% | |
market cap | 71.89M - | 71.89M 0% | 432.60M 501.79% | 677.79M 56.68% | 1.55B 129.28% | 6.22B 300.08% | 4.17B 32.98% | 957.79M 77.02% | 1.38B 44.07% | |
net current asset value | -293.15M - | -274.85M 6.24% | -216.86M 21.10% | -149.20M 31.20% | 12.22M 108.19% | 243.71M 1,893.73% | 407.17M 67.07% | 47.45M 88.35% | -182.42M 484.45% | |
net debt to ebitda | -14.40 - | -28.91 100.76% | 13.21 145.69% | 2.37 82.06% | 3.38 42.70% | 1.79 47.03% | 3.63 102.80% | 1.87 48.66% | -0.29 115.37% | |
net income per share | 0.13 - | -0.26 310.45% | -0.31 19.19% | -1.99 533.87% | -2.91 45.98% | -9.54 228.13% | -7.35 22.96% | -8.19 11.40% | -8.59 4.88% | |
operating cash flow per share | -16.11 - | -8.11 49.66% | -0.97 88.02% | -3.48 257.94% | -3.02 13.06% | -8.26 173.03% | -9.56 15.80% | -6.49 32.14% | -5.62 13.34% | |
payables turnover | 65.20 - | |||||||||
receivables turnover | 3.41 - | 1.58 53.76% | 0.41 - | |||||||
research and ddevelopement to revenue | 0.66 - | 0.70 5.77% | 0.79 13.31% | 1.48 87.41% | 1.82 22.41% | 4.83 166.12% | 17.64 265.09% | 13.58 23.03% | 76.64 464.54% | |
return on tangible assets | 0.01 - | -0.02 434.79% | -0.07 280.58% | -0.35 403.97% | -0.23 33.76% | -0.43 82.24% | -0.29 32.06% | -0.40 40.05% | -0.61 49.84% | |
revenue per share | 9.45 - | 9.15 3.15% | 2.52 72.50% | 2.01 20.19% | 1.93 3.66% | 0.87 54.93% | 0.27 69.31% | 0.32 18.24% | 0.06 80.71% | |
roe | -0.00 - | 0.01 311.29% | 0.02 305.41% | 0.32 1,407.19% | 0.19 40.92% | 0.41 113.12% | 0.26 36.69% | 0.24 8.40% | 4.75 1,904.59% | |
roic | -0.00 - | 0.01 335.34% | 0.02 281.55% | 0.37 1,523.24% | 0.24 35.90% | 0.75 216.47% | 0.24 68.11% | 0.25 4.59% | -1.56 725.70% | |
sales general and administrative to revenue | 0.22 - | 0.27 22.81% | 0.33 22.38% | 0.48 45.34% | 0.61 26.26% | 2.20 259.77% | 8.33 278.89% | 8.62 3.44% | 49.31 472.31% | |
shareholders equity per share | -49.86 - | -49.66 0.40% | -14.60 70.60% | -6.14 57.94% | -15.17 147.08% | -23.36 53.96% | -28.43 21.69% | -34.57 21.61% | -1.81 94.77% | |
stock based compensation to revenue | 0.03 - | 0.04 40.67% | 0.05 15.13% | 0.14 186.20% | 0.20 44.89% | 0.99 405.35% | 6.39 542.31% | 4.94 22.63% | 26.50 436.07% | |
tangible asset value | -274.25M - | -273.16M 0.40% | -215.05M 21.27% | -146.97M 31.66% | 15.16M 110.31% | 256.86M 1,594.42% | 417.43M 62.51% | 185.99M 55.44% | -65.69M 135.32% | |
tangible book value per share | -49.86 - | -49.66 0.40% | -10.85 78.15% | -6.14 43.41% | 0.55 108.91% | 8.45 1,443.31% | 12.38 46.63% | 5.12 58.65% | -1.81 135.32% | |
working capital | 48.60M - | 16.44M 66.18% | 27.65M 68.21% | 85.49M 209.17% | 286.35M 234.95% | 477.26M 66.67% | 728.14M 52.57% | 542.48M 25.50% | 338.81M 37.54% |
All numbers in USD (except ratios and percentages)